Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to ...
Griffith University researchers have shown that the shape and surface chemistry of microscopic "re-entrant" structures—tiny overhanging caps arranged like mushroom tops—can tune how cancer cells stick ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback